Zobrazeno 1 - 10
of 233
pro vyhledávání: '"E. De Mattia"'
Autor:
A. Bignucolo, E. De Mattia, R. Roncato, E. Peruzzi, L. Scarabel, M. D’Andrea, F. Sartor, G. Toffoli, E. Cecchin
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Awareness about the importance of implementing DPYD pharmacogenetics in clinical practice to prevent severe side effects related to the use of fluoropyrimidines has been raised over the years. Since 2012 at the National Cancer Institute,
Externí odkaz:
https://doaj.org/article/700446d8a4a048119e84e0552ffa9d97
Publikováno v:
Revista Portuguesa de Pneumologia (English Edition), Vol 23, Iss 4, Pp 236-239 (2017)
Externí odkaz:
https://doaj.org/article/0ce04d8f0bc444b0b66a2d21dad65a58
Publikováno v:
Monaldi Archives for Chest Disease, Vol 75, Iss 3 (2015)
Aim. To evaluate in a Pulmonary Rehabilitation (PR) setting the prevalence of airflow obstruction (AO) in either current or former smokers ≥45 years old both with dyspnoea and with chronic productive cough, using European Respiratory society (ERS)
Externí odkaz:
https://doaj.org/article/df5955bcf46044d6931b1ef5d99c58f8
Autor:
N. Barbarito, E. De Mattia
Publikováno v:
Monaldi Archives for Chest Disease, Vol 79, Iss 3-4 (2013)
Grading the severity of obstruction in patients with Chronic Obstructive Pulmonary Disease and morbid obesity. N. Barbarito, E. De Mattia. Aim. To evaluate the severity of airway obstruction in patients affected by chronic obstructive pulmonary disea
Externí odkaz:
https://doaj.org/article/a693be1edcd944a28c4ff99beffba9ed
Publikováno v:
European Journal of Public Health. 32
Background Breast Cancer (BC) is the most common type of cancer among women in Europe, accounting for around 28% of newly diagnosed female cancers. A clinical Pathway (CP) is an effective tool able to deliver high quality care especially if linked to
Autor:
E. Cecchin, Claudio Belluco, F. Navarria, Salvatore Pucciarelli, G. Toffoli, Vincenzo Canzonieri, E. Palazzari, A. De Paoli, Angela Buonadonna, E. De Mattia, Jerry Polesel, Roberto Innocente, Gaya Spolverato, Giovanni Franchin, A. Lauretta
Publikováno v:
Radiotherapy and Oncology. 161:S488-S489
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Marino Iatomasi, Christian Lunetta, Valeria A. Sansone, Barbara Garabelli, E. De Mattia, Fabrizio Rao
Publikováno v:
Revista Portuguesa de Pneumologia (English Edition), Vol 23, Iss 4, Pp 236-239 (2017)
Autor:
V Solfrini, E. De Mattia, Erika Cecchin, Rossana Roncato, Giuseppe Toffoli, Federico Innocenti, Angela Buonadonna, Luciana Giodini, Marcella Montico
Publikováno v:
Clinical Pharmacology & Therapeutics. 102:123-130
The adoption of a preemptive UGT1A1*28 genotyping to increase irinotecan safety in clinical practice is still limited. This is the first actual study of costs associated with the management of irinotecan-related toxicities, and their association with